CRAB / SLiM-CRAB Criteria

IMWG myeloma-defining events for the diagnosis of multiple myeloma
Clonal bone-marrow plasma cells
Biopsy-proven bony or extramedullary plasmacytoma
Myeloma-defining events (CRAB and SLiM biomarkers)
C — hypercalcaemia: serum calcium > 0.25 mmol/L (> 1 mg/dL) above the ULN, or > 2.75 mmol/L (> 11 mg/dL)
R — renal insufficiency: creatinine clearance < 40 mL/min, or serum creatinine > 177 µmol/L (> 2 mg/dL)
A — anaemia: haemoglobin > 20 g/L below the LLN, or < 100 g/L (< 10 g/dL)
B — ≥ 1 osteolytic lesion on skeletal radiography, CT, or PET-CT
Involved : uninvolved serum free light-chain ratio ≥ 100 (involved iFLC ≥ 100 mg/L)
> 1 focal lesion ≥ 5 mm on MRI

About this score

When to use

Checks the IMWG myeloma-defining events: the CRAB features (hypercalcaemia, renal insufficiency, anaemia, bone lesions) and three biomarkers of malignancy. ⁦[1]⁩

Pearls and pitfalls

• The biomarkers are clonal bone-marrow plasma cells of 60% or more, an involved:uninvolved free light-chain ratio of 100 or more, and more than one focal lesion on MRI. ⁦[1]⁩
• They apply when clonal bone-marrow plasma cells are 10% or more or a plasmacytoma is biopsy-proven. ⁦[1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Retained the CRAB features and added three biomarkers of malignancy (clonal bone-marrow plasma cells ≥ 60%, involved:uninvolved serum free light-chain ratio ≥ 100, and > 1 focal lesion on MRI) that also define myeloma requiring therapy.
Lancet Oncology, 2014
Open source
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore